BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31785169)

  • 1. Daylight photodynamic therapy for prevention of new actinic keratosis and keratinocyte carcinomas in organ transplants. A cryotherapy-controlled randomized clinical trial.
    Bernad I; Aguado L; Núñez-Córdoba JM; Redondo P
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1464-1470. PubMed ID: 31785169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial.
    Togsverd-Bo K; Lei U; Erlendsson AM; Taudorf EH; Philipsen PA; Wulf HC; Skov L; Hædersdal M
    Br J Dermatol; 2015 Feb; 172(2):467-74. PubMed ID: 24975199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
    O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
    JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
    Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
    Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daylight versus conventional photodynamic therapy for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials.
    Mei X; Wang L; Zhang R; Zhong S
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():23-28. PubMed ID: 30412779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization.
    Wenande E; Phothong W; Bay C; Karmisholt KE; Haedersdal M; Togsverd-Bo K
    Br J Dermatol; 2019 Apr; 180(4):756-764. PubMed ID: 30117140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
    Dirschka T; Ekanayake-Bohlig S; Dominicus R; Aschoff R; Herrera-Ceballos E; Botella-Estrada R; Hunfeld A; Kremser M; Schmitz B; Lübbert H; Puig S
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):288-297. PubMed ID: 30022544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment with topical 5-fluorouracil increases the efficacy of daylight photodynamic therapy for actinic keratoses - A randomized controlled trial.
    Wiegell SR; Fredman G; Andersen F; Bjerring P; Paasch U; Hædersdal M
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104069. PubMed ID: 38555038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study.
    Wennberg AM; Stenquist B; Stockfleth E; Keohane S; Lear JT; Jemec G; Mork C; Christensen E; Kapp A; Solvsten H; Talme T; Berne B; Forschner T
    Transplantation; 2008 Aug; 86(3):423-9. PubMed ID: 18698246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
    Morton C; Campbell S; Gupta G; Keohane S; Lear J; Zaki I; Walton S; Kerrouche N; Thomas G; Soto P;
    Br J Dermatol; 2006 Nov; 155(5):1029-36. PubMed ID: 17034536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
    Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
    Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
    Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
    Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
    Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical photodynamic therapy with methylaminolevulinate for the treatment of actinic keratosis and reduction of photodamage in organ transplant recipients: a case-series of 16 patients.
    Hasson A; Navarrete-Dechent C; Nicklas C; de la Cruz C
    Indian J Dermatol Venereol Leprol; 2012; 78(4):448-53. PubMed ID: 22772615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of reflectance confocal microscopy for monitoring treatment of actinic keratosis and field cancerization with daylight photodynamic therapy.
    Cavalcante RBM; Valente NYS; Ferreira PS; Neto CF; Torezan L
    Eur J Dermatol; 2023 Dec; 33(6):674-679. PubMed ID: 38465549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daylight photodynamic therapy versus cryosurgery for the treatment and prophylaxis of actinic keratoses of the face - protocol of a multicenter, prospective, randomized, controlled, two-armed study.
    Kohl E; Koller M; Zeman F; Szeimies RM; Philipp-Dormston WG; Prager W; Gerber PA; Karrer S
    BMC Dermatol; 2017 Oct; 17(1):12. PubMed ID: 29070025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-level light-assisted photodynamic therapy using a wearable cap-like device for the treatment of actinic keratosis of the scalp.
    Fonda-Pascual P; Alegre-Sánchez A; Harto-Castaño A; Moreno-Arrones OM; Pérez-García B; González-Morales ML; Pindado-Ortega C; Gilaberte-Calzada Y; Aguilera J; Jaen-Olasolo P; Fernández-Guarino M
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():136-141. PubMed ID: 30508663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.